Loading organizations...
Superstring Capital Management LP is a New York-based investment firm focused on the global healthcare sector. It employs a long-term, science-driven fundamental investing approach, targeting public and private opportunities across pharmaceuticals, biotechnology, medtech, and healthcare services. The firm emphasizes deep industry expertise and a collaborative partnership with portfolio companies.
Ting Guo founded Superstring Capital in 2019, driven by the insight that specialized, science-backed investment acumen was crucial for success in life sciences. Guo assembled a team of life sciences investment specialists, combining rigorous academic and business training with biopharma industry experience to navigate complex sector opportunities.
Superstring Capital deploys capital from a diverse institutional base, including university endowments, sovereign wealth funds, medical foundations, and family offices. Its vision is to leverage comprehensive industry, commercial, and regulatory knowledge as a trusted, long-term partner, fostering growth and sustained capital appreciation within the global healthcare ecosystem.
Superstring Capital has 10 tracked investments across 9 companies. The latest tracked deal is $200.0M Series C in Zenas BioPharma in May 2024.